News Formal

U.S. drugmaker earnings heat up this week with spotlight on vaccine news

  • 📰 Reuters
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Several major U.S. drugmakers will report second-quarter results this week, with investors eager for fresh details from Pfizer Inc , Merck & Co and others on their efforts to develop vaccines and therapies against the novel coronavirus.

Globally, drugmakers are expected to increase second-quarter earnings per share by 2%, after they rose 17% in the first quarter, according to Cowen & Co.

Pfizer, which has released early data on its vaccine candidate being developed with German biotech BioNTech SE , will kick off the week of drugmaker earnings on Tuesday morning. Gilead’s antiviral treatment, remdesivir, has become a key weapon for many countries after the intravenously administered medicine helped shorten hospital recovery times in a U.S. trial.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

Well, I never expected that ! 🤑

Hey Democrats! Here, money to redistribute! *crickets*

Don’t need it, Doc on steps has a cure.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 2. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

US stocks rise as tech trades higher, investors await stimulus bill | Markets InsiderUS stocks rose on Monday as investors looked to major earnings on deck this week and awaited the release of the GOP's coronavirus stimulus plan.... Meanwhile, their customers are getting screwed.
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »